It has also been found that the methylation level of the IL17RC promoter is significantly reduced in the retina, choroid, and peripheral blood of patients with AMD, leading to elevated IL17RC expression and that IL17RC may be a biomarker for AMD diagnosis 9. The gene discussed is IL17RC; the disease is age-related macular degeneration.